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Background: As healthy children are the main reservoir of respiratory pathogens and the main cause of bacterial
diffusion in the community, it could be interesting to investigate the type of screening that should be used during
the early years of life in order to obtain a more precise estimate of Staphylococcus aureus circulation. The aim of this
study was to evaluate oropharyngeal and nasal S. aureus carriage in otherwise healthy children and adolescents
aged 6–17 years.
Methods: The oropharyngeal and nasal samples were collected in December 2013 from 497 healthy students
attending five randomly selected schools in Milan, Italy, using an ESwab kit, and S. aureus was identified using the
RIDA®GENE methicillin-resistant S. aureus (MRSA) system.
Results: Two hundred and sixty-four subjects (53.1%) were identified as S. aureus carriers: 129 (25.9%) oropharyngeal
carriers and 195 (39.2%) nasal carriers, of whom 60 (12.1%) were both oropharyngeal and nasal carriers. Oropharyngeal
carriage increased with age (p < 0.001), whereas nasal carriage decreased. There was little or no agreement between
oropharyngeal and nasal carriage in any of the age groups. MRSA was identified in only three cases (0.6%), always in
nasal samples. There were no differences between the carriers and non-carriers in terms of the distribution of age,
gender, ethnicity, the number of siblings in the household, exposure to passive smoking, previous clinical history,
allergic sensitisation, or previous influenza, pneumococcal and meningococcal vaccinations. The frequency of male
children was higher among the subjects with positive nasal and oropharyngeal swabs (66.7%) than among those with
positive oropharyngeal swabs alone (46.4%; p = 0.02).
Conclusions: The oropharyngeal carriage of mainly methicillin-sensitive S. aureus is frequent in otherwise healthy
children, including a relatively high proportion of those without nasal colonisation. These findings highlight the
importance of adding throat to nasal screening when monitoring the circulation of S. aureus in the community.
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Staphylococcus aureusBackground
Staphylococcus aureus carriers are at increased risk of
developing S. aureus infections after invasive medical or
surgical procedures, and more frequently develop S. aureus
bacteremia when admitted to hospital [1]. Consequently,
routine admission screening is strongly recommended in
high-risk units, and the general screening of all hospita-
lised patients is debated [2]. The emergence of methicillin-* Correspondence: susanna.esposito@unimi.it
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unless otherwise stated.resistant S. aureus (MRSA), and evidence that difficult to
treat S. aureus-related diseases can also occur in the com-
munity has increased the importance of general screening
in order to monitor S. aureus circulation and its suscepti-
bility to antibiotics [3], and also explains why S. aureus
carriage in the community has recently been periodically
evaluated [4,5].
S. aureus screening is usually carried out using nasal
swabs because the anterior nares are considered the pri-
mary site of S. aureus colonisation, which can be found
in the nares of up to 40% of healthy subjects [6]. Add-
itional screening is currently considered unnecessary [1],l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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can also be an important site of S. aureus colonisation,
and that a relatively large number of subjects may be
colonised exclusively in the throat [7-11], and would be
missed by nasal screening. This has led some authors to
conclude that S. aureus screening should include both
nose and throat swabs in order to allow a complete
evaluation [12]. Most studies of throat carriage have in-
volved hospitalised adults, and there are very few data
concerning children. However, as healthy children are
the main reservoir of respiratory pathogens and the
main cause of bacterial diffusion in the community [1],
it could be interesting to investigate the type of screen-
ing that should be used during the early years of life in
order to obtain a more precise estimate of S. aureus
circulation.
The aim of this study was to evaluate oropharyngeal
and nasal S. aureus carriage in otherwise healthy chil-
dren and adolescents aged 6–17 years.
Methods
Swab collection
Oropharyngeal and nasal swabs were collected during
the second and third week of December 2013 from chil-
dren and adolescents attending five schools in Milan,
Italy (two primary schools, two middle schools, and one
high school), randomly selected with a computer-based
list from the public schools considered representative of
the middle class population living in Milan. Participation
was completely voluntary, but was solicited by means of
a letter and brochure distributed during lessons that de-
scribed the characteristics of the study in detail and re-
quested the written informed consent of both parents
and the signed assent of the study subjects. Moreover, in
order to maximise participation, all of the teachers rein-
forced the message in the week preceding the swabbing
by giving detailed explanations concerning S. aureus car-
riage and its related diseases.
The study was approved by the Ethics Committees of
the participating schools and the Fondazione IRCCS Ca’
Granda Ospedale Maggiore Policlinico, Milan, Italy. The
children were enrolled after parental consent and subject
assent had been obtained, and a brief demographic and
clinical questionnaire had been completed. Children
with a known, chronic underlying disease and those who
had been treated with antibiotics in the previous three
weeks were excluded from the study.
The swabbing was carried out in the medical room of
each school at the end of the lessons on two consecutive
days by a group of specifically trained pediatric residents
supervised by a pediatrician (NP) using an ESwab kit con-
taining a polypropylene screw-cap tube with an internal
conical shape filled with 1 mL liquid Amies medium (cat.
Number 480CE, Brescia, Copan, Italy). The oropharyngealsampling involved pressing the tongue downward to the
floor of the mouth by means of a spatula, and swabbing
both tonsillar arches and the posterior nasopharynx with-
out touching the sides of the mouth; the nasal sampling
involved inserting the swab tip into one nostril and rotat-
ing it for three seconds. All the swabs were immediately
transported to a central laboratory and processed within
two hours.Identification of S. aureus
S. aureus was identified using the RIDAGENE methicillin-
resistant S. aureus (MRSA) system (R-Biopharm AG,
Darmstadt, Germany) , a multiplex real-time PCR for the
direct, qualitative detection of MRSA and its differenti-
ation from methicillin-sensitive S. aureus (MSSA). It has
been validated for use with human nasal specimens and
cultures and has a detection limit of ≤5 DNA copies per
reaction [13].
DNA was extracted from the nasal and oral specimens
using 200 μL of lysis buffer (provided with the kit)
mixed with 100 μL of Copan swab transport media. The
preparation tubes were vortexed for 60 seconds, and in-
cubated in a heating block at 95°C for 10 minutes. The
samples were then centrifuged for one minute at
12,000 rpm and supernatant was collected. After DNA
isolation, the mecA/mecC gene, the SCCmec/orfX junc-
tion (type I, II, III, IV, V, VI, VII, IX and XI), and the orfX
gene specific for MRSA were amplified by means of Taq-
Man technology-based assays in accordance with the
manufacturer’s instructions. Each assay contains internal
control DNA, which is added to the samples in the ex-
traction step in order to detect possible PCR inhibition
or DNA extraction failure. The samples were classified
as negative if there was no amplification signal but the
internal control DNA was positive; MRSA if they were
positive for the mecA/mecC, the SCCmec/orfX junction
and the orfX gene; MSSA if they were positive for both
the SCCmec/orfX junction and the orfX gene, or only for
the orfX gene.Statistical analysis
The groups were compared using contingency table ana-
lysis with the chi-squared or Fisher’s exact test, as appro-
priate. A Cochran-Armitage test for trend was used to
compare the ordered categorical data between groups.
Subgroup analyses were made on the basis of age (<10,
10–14, and ≥15 years). Agreement between the oropha-
ryngeal and nasal swab results was examined by comput-
ing weighted kappa coefficients, using Fleiss-Cohen
weights. All of the tests were two-sided, and a p value of
<0.05 was considered statistically significant. The data
were analysed using SAS version 9.2 statistical software
(SAS Institute, Cary, NC, USA).
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The parents of more than 70% of the children attending
the selected schools agreed to allow their children to
take part in the study, but 35 (6.6%) of the 532 potential
participants were excluded because of mild upper re-
spiratory tract infections. Of the 497 remaining children,
264 (53.1%) were identified as S. aureus carriers: 129
(25.9%) oropharyngeal carriers and 195 (39.2%) nasal
carriers, of whom 60 (12.1%) were both oropharyngeal
and nasal carriers. This indicates that the use of oropha-
ryngeal swabs increased the identification of S. aureus
carriage by about 13.8%. Table 1 shows the oropharyn-
geal and/or nasal carriage of S. aureus in the study
population by age group and methicillin susceptibility.
Oropharyngeal carriage increased with age (p < 0.001),
whereas nasal carriage decreased. However, the differ-
ences between the age groups were statistically signifi-
cant only in the case of oropharyngeal carriage. There
was little or no agreement between oropharyngeal and
nasal carriage in any of the age groups. MRSA was iden-
tified in only three cases (0.6%), always in nasal samples.
Table 2 shows the general characteristics of the study
population by S. aureus carrier status. There were no
differences between the carriers and non-carriers in
terms of the distribution of age, gender, ethnicity, the
number of siblings in the household, exposure to passive
smoking, previous clinical history, allergic sensitisation,
or previous influenza, pneumococcal and meningococcal
vaccinations.
Table 3 shows the main characteristics of the children
carrying S. aureus by site of positivity. The children with
positive nasal swabs alone were younger than those with
positive oropharyngeal swabs alone (p < 0.001) or posi-
tive nasal and oropharyngeal swabs (p = 0.01). The fre-
quency of male children was higher among the subjects
with positive oropharyngeal and nasal swabs (66.7%)
than among those with positive oropharyngeal swabs
alone (46.4%; p = 0.02). There were no statisticallyTable 1 Oropharyngeal (OP) and nasal (NAS) carriage of Stap
age and S. aureus susceptibility to methicillin
Age group
<10 years 10-14 years
n = 199 n = 213
OP NAS Both OP NAS Bot
N (%) N (%) N (%) N (%) N (%) N (
MRSA 0 1 (0.5) 0 1 (0.5)
MSSA 42 (21.1) 77 (38.7) 51 (23.9) 89 (41.8)
Total S. aureus 42 (21.1) 78 (39.2) 21 (10.5) 51 (23.9) 90 (42.2) 24
MRSA: methicillin-resistant S. aureus; MSSA: methicillin-susceptible S. aureus; NAS: n
All of the Cohen’s kappa coefficients for agreement between total nasal and oropha
oropharyngeal S. aureus (and MSSA) carriage differed by age group (p < 0.001). Thesignificant differences in any of the other considered
characteristics.
This first study of oropharyngeal and nasal S. aureus
colonisation rates in healthy school children shows that,
like adults with a history of exposure to the healthcare
system [7-11], they frequently carry S. aureus in the
throat and that this may occur even in the absence of
nasal colonisation in a relatively high proportion of
cases. Although oropharyngeal sampling led to the de-
tection of S. aureus carriage in fewer children than nasal
sampling, it did identify about 14% of children who
would have been considered negative on the basis of a
nasal swab alone. The global carriage rate of more than
53% was similar to that observed in adults who have
provided both nasal and oropharyngeal samples [7-11],
but significantly higher than that reported in healthy
children who have undergone nasal evaluation alone [1],
thus highlighting the importance of throat sampling. In
this study S. aureus was identified by PCR assay and not
by culture. Consequently, genotyping or phenotyping
data of the pathogen cannot be presented and it was not
possible to establish whether more than one strain type
of S. aureus could be identified in children carrying this
pathogen. However, molecular techniques used in this
study can be adequate for an easier and faster epidemio-
logical evaluation of S. aureus carriage in the general
pediatric population in order to have useful information
concerning the circulation of MRSA in the community
and the risk of the occurrence of community acquired
(CA)-S. aureus illnesses that are potentially difficult to
treat. The very limited circulation of MRSA found in
this study could be, at least in part, due to the enrolment
of children who did not receive any antibiotic treatment
in the previous three weeks and for whom no antibiotic
selection of oropharyngeal flora favouring MRSA emer-
gence occurred. However, the finding suggests a mar-
ginal risk of CA disease due to MRSA in Milan:
however, it is worth remembering that, although suchhylococcus aureus by healthy children living in Milan by
≥15 years Total
n = 85 n = 497
h OP NAS Both OP NAS Both
%) N (%) N (%) N (%) N (%) N (%) N (%)
0 1 (1.2) 0 3 (0.6)
36 (42.3) 26 (30.6) 129 (26.0) 192 (38.6)
(11.3) 36 (42.3) 27 (31.8) 15 (17.6) 129 (26.0) 195 (39.2) 60 (12.1)
asal; OP: oropharyngeal.
ryngeal S. aureus carriage were <0.20 (no or little agreement). Total
re was no other significant age-related difference.
Table 2 Main characteristics of 497 healthy children by
Staphylococcus aureus carriage (positive nasal or
oropharyngeal swab, or both
All children
(n = 497)
Positive
(n = 264)
Negative
(n = 233)
p-value
Age (years)
<10 199 (40.0) 99 (49.7) 100 (50.3)
10-14 213 (42.9) 117 (54.9) 96 (45.1)
≥15 85 (17.1) 48 (56.5) 37 (43.5) 0.46
Sex
Male 281 (56.5) 151 (53.7) 130 (46.3)
Female 216 (43.5) 113 (52.3) 103 (47.7) 0.75
Ethnicitya
Caucasian 420 (84.8) 219 (52.1) 201 (47.9)
Non-caucasian 75 (15.2) 45 (60.0) 30 (40.0) 0.21
No. of siblingsa
0 127 (26.0) 66 (52.0) 61 (48.0)
1 270 (55.3) 143 (53.0) 127 (47.0)
2 69 (14.1) 38 (55.1) 31 (44.9)
≥3 22 (4.5) 14 (63.6) 8 (36.4) 0.37
Parental smoking
habita
Both non-smokers 390 (78.5) 207 (53.1) 183 (46.9)
At least one smoker 107 (21.5) 57 (53.3) 50 (46.7) 0.97
Gestational age
(weeks)a
<37 50 (14.2) 22 (44.0) 28 (56.0)
≥37 301 (85.8) 161 (53.5) 140 (46.5) 0.21
Birth weight (g)a
<2,500 28 (7.8) 11 (39.3) 17 (60.7)
≥2,500 332 (92.2) 174 (52.4) 158 (47.6) 0.18
Exclusive
breastfeedinga
No 113 (29.4) 54 (47.8) 59 (52.2)
Yes 271 (70.6) 141 (52.0) 130 (48.0) 0.45
Hospitalized for
acute diseases in
the last 3 months
No 474 (95.4) 254 (53.6) 220 (46.4)
Yes 23 (4.6) 10 (43.5) 13 (56.5) 0.34
Allergiesa
No 317 (75.3) 166 (52.4) 151 (47.6)
Yes 104 (24.7) 55 (52.9) 49 (47.1) 0.93
Allergic
sensitizationa
No 338 (81.4) 172 (50.9) 166 (49.1)
Yes 77 (18.6) 45 (58.4) 32 (41.6) 0.23
Table 2 Main characteristics of 497 healthy children by
Staphylococcus aureus carriage (positive nasal or
oropharyngeal swab, or both (Continued)
Flu vaccination
during current
seasona
No 365 (93.8) 185 (50.7) 180 (49.3)
Yes 24 (6.2) 11 (45.8) 13 (54.2) 0.65
Pneumococcal
vaccinationa
No 351 (71.0) 195 (55.6) 156 (44.4)
Yes 143 (29.0) 67 (46.8) 76 (53.1) 0.08
Meningococcal
vaccination
No 303 (61.0) 168 (55.4) 135 (44.6)
Yes 194 (39.0) 96 (49.5) 98 (50.5) 0.19
aThe sum does not add up to the total because of missing values.
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population of Europe, they are considerably more fre-
quent in intensive care units and hospital wards caring
for patients with chronic diseases [14-16].
The fact that the rates of exclusively oropharyngeal
carriage were significantly higher among the older chil-
dren suggests that age may play a role in conditioning
the site of colonisation. The carriage of respiratory bac-
teria is strictly age dependent as it is significantly higher
in younger children than in adolescents [17], and is
modified by vaccine use [18]. Moreover, there are data
showing that the primary site of colonisation of bacteria
such as Streptococcus pneumoniae can vary with age
[19]. As it has been demonstrated that significant inter-
actions can occur between bacterial species and be-
tween bacteria and viruses, and that these can affect
the carriage rates of a given infectious agent [20], it
can be hypothesised that the age-related differences in
pharyngeal S. aureus colonisation rates may be due to
time-related variations in bacterial balance in different
body sites.
Regardless of age, a minority of children showed both
oropharyngeal and nasal colonisation. This is different
from the findings of some adult studies indicating that
bacterial colonisation in the nose is almost always ac-
companied by colonisation in the throat [7]. However,
the difference may be due to the different characteristics
of the studied subjects: we only enrolled otherwise
healthy children with little or no exposure to the health-
care system, whereas the adult studies mainly involved
hospitalised patients. Furthermore, the adult studies also
showed that dual colonisation is significantly more fre-
quent in subjects in close contact with other S. aureus
carriers, such as frequently hospitalised patients [9].
Table 3 Main characteristics of 497 healthy children by
Staphylococcus aureus carriage as assessed by means of
oropharyngeal (OP) or nasal (NAS) swabs or both
OP positive
only (n = 69)
NAS positive
only (n = 135)
OP and NAS
positive
(n = 60)
Age (years)b
<10 21 (30.4) 57 (42.2) 21 (35.0)
10-14 27 (39.1) 66 (48.9) 24 (40.0)
≥15 21 (30.4) 12 (8.9) 15 (25.0)
Sexb
Male 32 (46.4) 79 (58.5) 40 (66.7)
Female 37 (53.6) 56 (41.5) 20 (33.3)
Ethnicitya
Caucasian 61 (88.4) 109 (80.7) 49 (81.7)
Non-caucasian 8 (11.6) 26 (19.3) 11 (18.3)
No. of siblingsa
0 15 (22.1) 34 (25.2) 17 (29.3)
1 42 (61.8) 71 (52.6) 30 (51.7)
2 9 (13.2) 21 (15.6) 8 (13.8)
≥3 2 (2.9) 9 (6.7) 3 (5.2)
Parental smoking
habita
Both non-smokers 55 (79.7) 108 (80.0) 44 (73.3)
At least one smoker 14 (20.3) 27 (20.0) 16 (26.7)
Gestational age
(weeks)a
<37 2 (5.3) 16 (14.3) 4 (12.1)
≥37 36 (94.7) 96 (85.7) 29 (87.9)
Birth weight (g)a
<2,500 2 (5.4) 7 (6.1) 2 (5.9)
≥2,500 35 (94.6) 107 (93.9) 32 (94.1)
Exclusive
breastfeedinga
No 12 (30.0) 33 (28.0) 9 (24.3)
Yes 28 (70.0) 85 (72.0) 28 (75.7)
Hospitalized for acute
diseases in the last
3 months
No 65 (94.2) 131 (97.0) 58 (96.7)
Yes 4 (5.8) 4 (3.0) 2 (3.3)
Allergiesa
No 38 (74.5) 97 (77.6) 31 (68.9)
Yes 13 (25.5) 28 (22.4) 14 (31.1)
Allergic
sensitizationa
No 38 (76.0) 101 (80.8) 33 (78.6)
Yes 12 (24.0) 24 (19.2) 9 (21.4)
Table 3 Main characteristics of 497 healthy children by
Staphylococcus aureus carriage as assessed by means of
oropharyngeal (OP) or nasal (NAS) swabs or both
(Continued)
Flu vaccination
during current
seasona
No 36 (90.0) 115 (95.8) 34 (94.4)
Yes 4 (10.0) 5 (4.2) 2 (5.6)
Pneumococcal
vaccinationa
No 54 (79.4) 94 (69.6) 47 (79.7)
Yes 14 (20.6) 41 (30.4) 12 (20.3)
Meningococcal
vaccination
No 45 (65.2) 83 (61.5) 40 (66.7)
Yes 24 (34.8) 52 (38.5) 20 (33.3)
aThe sum does not add up to the total because of missing values.
bThe frequency distribution was significantly different according to age
between NAS positive and OP positive children (p < 0.001) and between NAS
positive and OP and NAS positive children (p = 0.01), and according to sex
between OP positive and OP and NAS positive children (p = 0.02). No other
statistically significant differences emerged for any of the other characteristics
considered.
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Although it has not been established what risk oropha-
ryngeal carriers represent in terms of bacterial spread
and infection, the findings of this study highlight the im-
portance of adding throat to nasal screening when moni-
toring the circulation of S. aureus in the community.
The additional cost of throat screening could be mini-
mised by pooling samples in the laboratory and, as in
this study, using molecular methods that are more cost-
effective for screening S. aureus than traditional cultures
because of the high cost of unnecessary isolation [21].Abbreviations
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